Primary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents.

TitlePrimary central nervous system lymphoma: initial features, outcome, and late effects in 75 children and adolescents.
Publication TypeJournal Article
Year of Publication2019
AuthorsAttarbaschi A, Abla O, Ronceray L, Bansil S, Bomken S, Burkhardt B, Ceppi F, Chiang AKS, Dave H, Fedorova A, Henry M, Jazbec J, Kabickova E, Kotecha RS, Lazic J, Loeffen J, Miakova N, Osumi T, Pillon M, Pourtsidis A, Rigaud C, Tamamyan G, Tandon S, Uyttebroeck A, Verdu-Amoros J, Woessmann W, Wrobel G, Giulino-Roth L
JournalBlood Adv
Volume3
Issue24
Pagination4291-4297
Date Published2019 Dec 23
ISSN2473-9537
Abstract

Children with PCNSL and no immunodeficiency have a good outcome when treated by a histological subtype–driven and radiation-free protocol. New treatment guidelines are needed for PCNSL in children and adolescents with an underlying immunodeficiency.

DOI10.1182/bloodadvances.2019001062
Alternate JournalBlood Adv
PubMed ID31869415
PubMed Central IDPMC6929389
Grant ListK08 CA219473 / CA / NCI NIH HHS / United States